Article Correctness Is Author's Responsibility: New radiopharmaceutical shows promise for improved detection of neuroendocrine tumors

(Society of Nuclear Medicine and Molecular Imaging) A newly developed imaging agent has emerged as a promising aid for diagnosis of neuroendocrine cancer, according to research published in The Journal of Nuclear Medicine.